Thank you, Madam Chair.
I would first like to thank all the witnesses who are here today for their relevant presentations.
My question is for anyone who can answer it.
There are numerous academic, government and hospital-based organizations and agencies that undertake health technology assessments (HTAs) in Canada. The Canadian Agency for Drugs and Technologies in Health (CADTH) is a non-profit organization established by the federal, provincial and territorial governments in 1989 to ensure that policy makers have access to evidence-based assessment of the clinical and cost effectiveness of pharmaceuticals and health technologies.
How does the work undertaken by CADTH differ from that of other health technology assessment organizations in Canada? Furthermore, in your view, what steps could CADTH take to coordinate efforts in health technology assessment in order to avoid duplication of efforts and possible inefficiencies in this area? Finally, in your view, are policy makers more likely to adopt the recommendations made by CADTH regarding funding decisions for drugs and technologies, or are they more likely to adopt the recommendations made by local health technology assessment organizations?
Thank you.